|
Product Name |
Cat# |
Product Description |
Size A |
Size B |
Size C |
|
rHAVVP1-P2A |
HAV- 228 |
Recombinant Hepatitis A Virus VP1-P2A (669-782 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHAVVP1-P2AM |
HAV- 265 |
Recombinant Hepatitis A Virus VP1-P2A Mosaic (669-782, 722-830 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHAVP2C |
HAV- 229 |
Recombinant Hepatitis A Virus P2C (1211-1234 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHAVP2C-P3AM |
HAV- 230 |
Recombinant Hepatitis A Virus P2C-P3A Mosaic (1392-1521, 1492-1606
a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHAVP2C-P3AM13-15 |
HAV- 266 |
Recombinant Hepatitis A Virus P2C-P3A (1392-1521 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHAVP2C-P3AM14-16 |
HAV- 267 |
Recombinant Hepatitis A Virus P2C-P3A (1492-1606 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHAVP3C |
HAV- 231 |
Recombinant Hepatitis A Virus P3C (1643-1743 a.a) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHAVVP3 |
HAV- 226 |
Recombinant Hepatitis A Virus VP3 (304-415 a.a) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHAVVP4-VP2 |
HAV- 225 |
Recombinant Hepatitis A Virus VP4-VP2 (55-164 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHBcAg-186 |
HBV- 232 |
Recombinant Hepatitis B Virus Core (1-186 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHBcAg-183 |
HBV- 269 |
Recombinant Hepatitis B Virus Core (1-183 a.a.), 18kDa |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rHBcAg-144 |
HBV- 270 |
Recombinant Hepatitis B Virus Core (1-144 a.a.), 16kDa |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rHBVHBe |
HBV- 233 |
Recombinant Hepatitis B Virus HBe |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHDV |
HDV- 234 |
Recombinant Hepatitis D Virus (1-108 .aa.), (151-209 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHEVORF2/ORF3 |
HEV- 274 |
Recombinant Hepatitis E Virus Mosaic-S ORF2/ORF3 (4 HEV immunodominant
regions) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHEVORF2/ORF3 |
HEV- 235 |
Recombinant Hepatitis E Virus Mosaic ORF2/ORF3 (12 HEV immunodominant
regions) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHEVORF2-633 |
HEV- 271 |
Recombinant Hepatitis E Virus ORF2 (633-659 a.a.) |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rHEVORF2-403 |
HEV- 272 |
Recombinant Hepatitis E Virus ORF2 (403-461 a.a.) |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rHEVORF2-92 |
HEV- 273 |
Recombinant Hepatitis E Virus ORF2 (92-123 a.a.) |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rHEVORF2-452 |
HEV- 236 |
Recombinant Hepatitis E Virus ORF2 (452-617 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHBsAgayw |
HBS- 870 |
Recombinant Hepatitis B Surface Antigen ayw subtype, Saccharomyces
derived |
370 |
100΅g |
650 |
500΅g |
950 |
1mg |
|
rHBsAgadr |
HBS- 873 |
Recombinant Hepatitis B Surface Antigen adr subtype |
370 |
100΅g |
650 |
500΅g |
950 |
1mg |
|
rHBsAgadw |
HBS- 872 |
Recombinant Hepatitis B Surface Antigen Adw subtype |
370 |
100΅g |
650 |
500΅g |
950 |
1mg |
|
rHBsAgaywp |
HBS- 880 |
Recombinant Hepatitis B Surface Antigen ayw subtype, pichia derived |
370 |
100΅g |
650 |
500΅g |
950 |
1mg |
|
rCMVgB |
CMV- 211 |
Recombinant Cytomegalo Virus gB (11-76 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rCMVPp28(UL99) |
CMV- 212 |
Recombinant Cytomegalo Virus pP28 (UL99) (130-160 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rCMVPp38(UL80a) |
CMV- 213 |
Recombinant Cytomegalo Virus Pp38 (UL80a) (117-373 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rCMVPp52(UL44) |
CMV- 214 |
Recombinant Cytomegalo Virus pP52 (UL44) (202-434 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rCMVPp65(UL83) |
CMV- 215 |
Recombinant Cytomegalo Virus pP65(UL83) (297-510 a.a.), 52,282 Dalton |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rCMVPp150(UL32) |
CMV- 216 |
Recombinant Cytomegalo Virus pP150(UL32) (1011-1048 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rVZVgE |
VZV- 231 |
Recombinant Varicella Zoster Virus gE (48-135 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rVZVORF9 |
VZV- 232 |
Recombinant Varicella Zoster Virus ORF9 (6-28/76-100 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rVZVORF26 |
VZV- 233 |
Recombinant Varicella Zoster Virus ORF26 (9-33/184-208) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rTGMIC3 |
TOX- 261 |
Recombinant Toxoplasma Gondii MIC3 (234-306a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rTPGP24(GRA1) |
TOX- 262 |
Recombinant Toxoplasma Gondii P24 (GRA 1) (57-149 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rTPGP29(GRA7) |
TOX- 263 |
Recombinant Toxoplasma Gondii P29 (GRA 7) (24-100 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rTPGP30(SAG1) |
TOX- 264 |
Recombinant Toxoplasma Gondii P30 (SAG 1) (45-198 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rTRPp17 |
TRP- 241 |
Recombinant Treponema pallidum p17 |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rTRPp15 |
TRP- 275 |
Recombinant Treponema pallidum p15 |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rTRPp41 |
TRP- 242 |
Recombinant Treponema pallidum p41 |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rTRPp47 |
TRP- 243 |
Recombinant Treponema pallidum p47 |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rTRPM |
TRP- 244 |
Recombinant Treponema pallidum Mosaic |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rTmpA |
TRP- 245 |
Recombinant Treponema pallidum TmpA |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rHIV-I |
HIV- 101 |
Recombinant HIV-I Envelope (spanning C-terminus of gp120 and gp41) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-Ip24c |
HIV- 109 |
Recombinant HIV-I p24 Core (spanning all of p24) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-Ip24 |
HIV- 116 |
Recombinant HIV-I p24 |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-Ip24-biotin |
HIV- 117 |
Recombinant HIV-I p24, biotin conjugate |
190 |
100΅g |
435 |
500΅g |
730 |
1000΅g |
|
rHIV-Ip24-hrp |
HIV- 118 |
Recombinant HIV-I p24, Horseradish peroxidase labled |
190 |
100΅g |
435 |
500΅g |
730 |
1000΅g |
|
rHIV-Ip17/24/120/41 |
HIV- 119 |
Recombinant HIV-I gag p17, p24, gp120, gp41 |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-Ip17/24/120 |
HIV- 120 |
Recombinant HIV-I gag p17, p24, gp120 |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-Igp41 |
HIV- 121 |
Recombinant HIV-I gp41 |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-Igp41L |
HIV- 122 |
Recombinant HIV-I gp41 Long |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-Igp41-32kDa |
HIV- 134 |
Recombinant HIV-I gp41 (466-753 a.a.) 32kDa |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rHIV-Igp41-biotin |
HIV- 123 |
Recombinant HIV-I gp41, biotin conjugate |
190 |
100΅g |
435 |
500΅g |
730 |
1000΅g |
|
rHIV-Igp41-hrp |
HIV- 124 |
Recombinant HIV-I gp41, Horseradish peroxidase labled |
190 |
100΅g |
435 |
500΅g |
730 |
1000΅g |
|
rHIV-Igp41L-biotin |
HIV- 125 |
Recombinant HIV-I gp41 Long, biotin conjugate |
190 |
100΅g |
435 |
500΅g |
730 |
1000΅g |
|
rHIV-Igp41L-hrp |
HIV- 126 |
Recombinant HIV-I gp41 Long, Horseradish peroxidase labled |
190 |
100΅g |
435 |
500΅g |
730 |
1000΅g |
|
rHIV-Ip17/24 |
HIV- 127 |
Recombinant HIV-I gag p17, p24 |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-Igp32 |
HIV- 128 |
Recombinant HIV-I gp32 |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-Igp32-biotin |
HIV- 129 |
Recombinant HIV-I gp32, biotin conjugate |
190 |
100΅g |
435 |
500΅g |
730 |
1000΅g |
|
rHIV-Igp32-hrp |
HIV- 130 |
Recombinant HIV-I gp32, Horseradish peroxidase labled |
190 |
100΅g |
435 |
500΅g |
730 |
1000΅g |
|
rHIV-IRT |
HIV- 136 |
Recombinant HIV-I pol Reverse Transcriptase |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-I-int |
HIV- 137 |
Recombinant HIV-I pol Integrase |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIVOe |
HIV- 131 |
Recombinant HIV Tyoe O Envelope |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-IIgp32 |
HIV- 132 |
Recombinant HIV-II gp32 |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-IIgp36 |
HIV- 133 |
Recombinant HIV-II gp36 |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-Igp36-34kDa |
HIV- 135 |
Recombinant HIV-II gp36 (390-702 a.a), 34kDa |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rHIV-Ip24gag |
HIV- 140 |
Recombinant HIV-I gag p24 77-436 a.a. , 39kDa |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rHIV-Inef |
HIV- 138 |
Recombinant HIV-I nef 3-190 a.a. , 20kDa |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rHIV-Igp160LAV |
HIV- 110 |
Recombinant HIV-I gp160 LAV |
260 |
10΅g |
500 |
50΅g |
5.600 |
1mg |
|
rHIV-Igp160MN |
HIV- 111 |
Recombinant HIV-I gp160 MN |
310 |
10΅g |
625 |
50΅g |
6.475 |
1mg |
|
rHIVp66pol |
HIV- 112 |
Recombinant HIV-I p66 pol |
260 |
10΅g |
500 |
50΅g |
4.775 |
1mg |
|
rHIV-ITAT |
HIV- 139 |
Recombinant HIV-I TAT |
310 |
10΅g |
625 |
50΅g |
6.475 |
1mg |
|
rHIV-Ip55gag |
HIV- 113 |
Recombinant Human HIV-I p55 gag |
310 |
10΅g |
625 |
50΅g |
6.475 |
1mg |
|
rHIV-I,II |
HIV- 106 |
Recombinant HIV-I Envelope conjugated to a gp39 HIV-II |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHIV-II |
HIV- 102 |
Recombinant HIV-II Envelope |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rSIVp55 |
SIV- 114 |
Recombinant Human SIV p55 |
260 |
10΅g |
500 |
50΅g |
5.600 |
1mg |
|
rHTLV-I |
HIV- 107 |
Recombinant HTLV-I Envelope |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHTLV-Ip24c |
HIV- 108 |
Recombinant HTLV-I p24 Core |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHTLV-Im |
HIV- 144 |
Recombinant HTLV-I Mosaic (374-400/190-207a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHTLV-I+II |
HIV- 115 |
Recombinant HTLV-I+II |
310 |
100΅g |
940 |
500΅g |
1.500 |
1000΅g |
|
rEBV(HHV-4)M |
EBV- 271 |
Recombinant Epstein-Barr Virus (HHV-4) Mosaic EBNA1(1-90, 408-498 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rEBV(HHV-4)EA |
EBV- 272 |
Recombinant Epstein-Barr Virus (HHV-4) EA (306-390a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rEBV(HHV-4)p18 |
EBV- 273 |
Recombinant Epstein-Barr Virus (HHV-4) p18 (1-119 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rEBV(HHV-4)p23 |
EBV- 274 |
Recombinant Epstein-Barr Virus (HHV-4) p23 (1-162 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rTBEVgE |
TBE- 281 |
Recombinant Tick-Born Encephalitis Virus gE (95-229 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rRVE1M |
RUB- 291 |
Recombinant Rubella Virus E1 Mosaic (157-176, 374-390, 213-239a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rRVE2 |
RUB- 292 |
Recombinant Rubella Virus E2 (31-105 a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rRVCC |
RUB- 293 |
Recombinant Rubella Virus Capsid C (1-123a.a.) |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rRVE1E2C |
RUB- 878 |
Recombinant Rubella Virus E1, E2 & c-core |
170 |
100΅g |
345 |
500΅g |
520 |
1000΅g |
|
rHA |
IHA- 001 |
Recombinant Hemagglutinin |
260 |
10΅g |
500 |
50΅g |
5.600 |
1mg |
|
InfluBeijing |
IHA- 002 |
Influenza A Virus (H1N1) |
325 |
100΅g |
675 |
500΅g |
1.000 |
1mg |
|
InfluCaledonia |
IHA- 003 |
Influenza A Virus (H1N1) |
325 |
100΅g |
675 |
500΅g |
1.000 |
1mg |
|
InfluShandong |
IHA- 004 |
Influenza A Virus (H3N2) |
325 |
100΅g |
675 |
500΅g |
1.000 |
1mg |
|
InfluKiev |
IHA- 005 |
Influenza A Virus (H3N2) |
325 |
100΅g |
675 |
500΅g |
1.000 |
1mg |
|
InfluPanama |
IHA- 006 |
Influenza A Virus (H3N2) |
325 |
100΅g |
675 |
500΅g |
1.000 |
1mg |
|
InfluTaiwan |
IHA- 007 |
Influenza A Virus (H1N1) |
325 |
100΅g |
675 |
500΅g |
1.000 |
1mg |
|
rHuHSP20 |
HSP- 020 |
Recombinant Human Heat Shock Protein 20 |
135 |
2΅g |
190 |
10΅g |
700 |
100΅g |
|
rHuHSP22 |
HSP- 022 |
Recombinant Human Heat Shock Protein 22 |
135 |
2΅g |
190 |
10΅g |
700 |
100΅g |
|
rHuHSP25 |
HSP- 025 |
Recombinant Human Heat Shock Protein 25 |
135 |
2΅g |
190 |
10΅g |
550 |
100΅g |